Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression

Positive Early Signals Seen in Two Investigator-Initiated Studies Presented at the Society of Biological Psychiatry Annual Meeting in New Orleans COMPASS Pathways (COMPASS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that positive data two investigator-initiated studies demonstrating the potential of COMP360 psilocybin therapy in anorexia […]

Studies show psilocybin therapy has potential for anorexia nervosa and severe treatment-resistant depression Read More »